Viveve to Participate in H.C. Wainwright 24th Annual Global Investment Conference
Press release content from Accesswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Viveve Systems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Accesswire. The AP news staff was not involved in its creation.
Total revenue of $1.8 million in Q2 including sale of 2,850 disposable treatment tipsPURSUIT clinical trial follow-up visit completion anticipated by year endConference call to be hosted by Company at
ENGLEWOOD, CO / ACCESSWIRE / July 12, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced
Press release content from Accesswire. The AP news staff was not involved in its creation.
Reported total revenue for year end 2021 of $6.4 million representing 17% year-over-year growthEnrollment completed in U.S. pivotal PURSUIT trial for stress urinary incontinence and 12-month post treatment